Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Pranzatelli

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Archives of Neurology|June 1, 1994
Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonistsM R Pranzatelli
Pediatric Annals|January 1, 1993
Myoclonic disordersM R Pranzatelli
Clinical Neuroscience (New York, N.Y.)|January 1, 1995
The pharmacology of antimyoclonic drugsM R Pranzatelli
Medical Hypotheses|September 1, 1989
The proposed role of neurotransmitter receptors in the pathophysiology of human myoclonic disordersM R Pranzatelli
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Peripheral neurological paraneoplastic syndromesM R Pranzatelli
Clinical Neuropharmacology|June 1, 1992
The neurobiology of the opsoclonus-myoclonus syndromeM R Pranzatelli
Brain Research Bulletin|July 1, 1990
Neonatal 5,7-DHT lesions upregulate [3H]mesulergine-labelled spinal 5-HT1C binding sites in the ratM R Pranzatelli
Neuroscience Letters|July 17, 1990
Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI)M R Pranzatelli
Neuroscience Letters|January 4, 1993
Regional differences in the ontogeny of 5-hydroxytryptamine-1C binding sites in rat brain and spinal cordM R Pranzatelli
Pediatric Annals|January 1, 1993
Miscellaneous movement disorders of childhoodM R Pranzatelli
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Archives of Neurology|June 1, 1994
Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonistsM R Pranzatelli
Pediatric Annals|January 1, 1993
Myoclonic disordersM R Pranzatelli
Clinical Neuroscience (New York, N.Y.)|January 1, 1995
The pharmacology of antimyoclonic drugsM R Pranzatelli
Medical Hypotheses|September 1, 1989
The proposed role of neurotransmitter receptors in the pathophysiology of human myoclonic disordersM R Pranzatelli
Drugs of Today (Barcelona, Spain : 1998)|February 28, 2004
Peripheral neurological paraneoplastic syndromesM R Pranzatelli
Clinical Neuropharmacology|June 1, 1992
The neurobiology of the opsoclonus-myoclonus syndromeM R Pranzatelli
Brain Research Bulletin|July 1, 1990
Neonatal 5,7-DHT lesions upregulate [3H]mesulergine-labelled spinal 5-HT1C binding sites in the ratM R Pranzatelli
Neuroscience Letters|July 17, 1990
Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI)M R Pranzatelli
Neuroscience Letters|January 4, 1993
Regional differences in the ontogeny of 5-hydroxytryptamine-1C binding sites in rat brain and spinal cordM R Pranzatelli
Pediatric Annals|January 1, 1993
Miscellaneous movement disorders of childhoodM R Pranzatelli
Pageof 10